What is Ekatherina Goryachikov email address?

Ekatherina Goryachikov's primary email address is ************@adicetbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Ekatherina Goryachikov work for?

Ekatherina Goryachikov is a VP and Head of Clinical Operations at Adicet Bio, Inc, a company specializing in Commercial physical research.

Where Ekatherina Goryachikov graduated from?

Ekatherina Goryachikov holds a degree in Clinical Trials Design And Management from University of California Santa Cruz.

How can I directly contact Ekatherina Goryachikov?

To contact Ekatherina Goryachikov directly, you can use the email address ************@adicetbio.com. Complete contact information is available upon registration with Muraena.

Who is Ekatherina Goryachikov?

Ekatherina Goryachikov is a seasoned professional in the biopharmaceutical sector, currently serving as the VP and Head of Clinical Operations at Adicet Bio. With a robust background in clinical operations, she has held significant leadership roles in various organizations, including Allogene Therapeutics and Iovance Biotherapeutics. Her expertise encompasses a wide range of areas such as clinical data management, drug development, and regulatory submissions, making her a pivotal figure in advancing clinical research. Ekatherina's academic foundation in biochemistry and clinical trials design equips her with the necessary skills to navigate complex clinical landscapes. She has demonstrated a consistent trajectory of professional growth, moving from clinical research associate roles to senior leadership positions. Her experience spans both startup and established corporate environments, showcasing her adaptability. Passionate about innovation and therapeutic advancements, she is well-versed in navigating the intricacies of clinical trial management and compliance. Ekatherina's commitment to excellence is evident in her strategic approach to clinical operations, where she aims to streamline processes and enhance patient outcomes.